Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
China Claims 100 Intellectual Property Rights on Human Functional Genes
1/9/2006
BEIJING, Jan. 7 (Xinhua) -- Chinese scientists have claimed nearly 100 intellectual property rights on human functional genes, which have shown great potential in disease prevention and pharmaceutical development.
Sources with the Ministry of Science and Technology (MOST) said here Saturday that the great progress in human genome research is an important step of the "863" high-technology program, a national project initiated in March 1986 aiming to enhance the country's overall strength.
So far, Chinese scientists have established a platform for selecting human functional genes, cloned and identified 1,346 new genes, and carried out large scale examination of genetic functions. Among the 100 human functional genes with Chinese intellectual property rights, 20 or more are now in the initial stage of laboratory research.
In the meantime, the MOST said, progress has also been made in research on genes relevant to tumour and cardiovascular diseases and the causes of the diseases, and a group of genes related to heredity diseases have been cloned and identified, such as cataract and epilepsy among children. These research results have been published in the journals of "Science" and "Nature", laying a sound technological foundation for the diagnosis and treatment of heredity diseases. Besides, Chinese scientists have also scored remarkable achievements in genome research such as on rice, microorganism, silkworm, and schistosome.
Relate News
more
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit